Global Whole Genome Sequencing Market Size To Exceed USD 18.35 Billion By 2035 | CAGR of 22.05%
Category: HealthcareGlobal Whole Genome Sequencing Market Size To Exceed USD 18.35 Billion By 2035
According to a research report published by Spherical Insights & Consulting, the Global Whole Genome Sequencing Market Size is Expected to Grow from USD 2.05 Billion in 2024 to USD 18.35 billion by 2035, at a CAGR of 22.05% during the forecast period 2025-2035.
Get more details on this report -
Browse key industry insights spread across 240 pages with 130 Market data tables and figures & charts from the report on the "Global Whole Genome Sequencing Market Size, Share, and COVID-19 Impact Analysis, By Product & Service (Instruments, Consumables, and Services), By Application (Human Whole Genome Sequencing, Plant Whole Genome Sequencing, Animal Whole Genome Sequencing, and Microbial Whole Genome Sequencing), By End-use (Academic & Research Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 – 2035." Get Detailed Report Description: https://www.sphericalinsights.com/reports/whole-genome-sequencing-market
The whole genome sequencing market is the market focusing on the analysis of the complete DNA sequence of an organism. Whole genome sequencing is a comprehensive method for analysing entire genomes, which can detect single-nucleotide variants, insertions/deletions, copy number changes, and large structural variants. Transformation of the genomics landscape, impacting the healthcare, research, and agriculture sectors, aids in promoting the whole genome sequencing market. Further, the growing demand for long-read sequencing in clinical genomics is providing the market opportunities. The growing prevalence of genetic disorders, along with increasing technological advancements in the genomics industry, is driving the whole genome sequencing market. On the contrary, the increased privacy concerns related to whole genome sequencing and limited expertise & sequencing capabilities of small and medium-sized laboratories are challenging the market.
The consumables segment accounted for the dominant revenue share in 2024 and is projected to grow at a substantial CAGR during the forecast period.
Based on the product & service, the whole genome sequencing market is divided into instruments, consumables, and services. Among these, the consumables segment accounted for the dominant revenue share in 2024 and is projected to grow at a substantial CAGR during the forecast period. Technological advancements in sequencing, along with heightened focus on genomics research, are propelling the whole genome sequencing market in the consumables segment.
The human whole genome sequencing segment accounted for the largest revenue share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period.
Based on the application, the whole genome sequencing market is divided into human whole genome sequencing, plant whole genome sequencing, animal whole genome sequencing, and microbial whole genome sequencing. Among these, the human whole genome sequencing segment accounted for the largest revenue share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. Human whole genome sequencing is the most comprehensive application for detecting all variant types of the human genome in a single assay, which aids in the development of targeted therapies to treat diseases.
The academic & research institutes segment accounted for the largest market share in 2024 and is anticipated to grow at a significant CAGR during the forecast period.
Based on the end-use, the whole genome sequencing market is divided into academic & research institutes, hospitals & clinics, pharmaceutical & biotechnology companies, and others. Among these, the academic & research institutes segment accounted for the largest market share in 2024 and is anticipated to grow at a significant CAGR during the forecast period. The growing adoption of whole genome sequencing technologies by the academic & research institutes for drug research and genomic studies is responsible for driving the market.
North America is expected to hold the majority share of the global whole genome sequencing market during the forecast period.
Get more details on this report -
North America is expected to hold the majority share of the global whole genome sequencing market during the forecast period. An upsurge in advancements in personalized medicine, with increasing research funding, is propelling the market growth. Significant research investments by the pharmaceutical and biopharmaceutical companies, along with the region’s increased awareness about whole genome sequencing, are contributing to driving the market growth.
Asia Pacific is anticipated to grow at the fastest pace in the global whole genome sequencing market during the forecast period. An increasing awareness about personalized medicine, government initiatives, and academic institutes' collaborations with biotech companies are significantly contributing to promoting the market. Genomics advancements, along with an increased prevalence of genetic disorders, are anticipated to drive the whole genome sequencing market.
Europe is anticipated to grow at a significant CAGR in the whole genome sequencing market during the predicted timeframe. The growing investments in advanced sequencing technologies by the healthcare institutions, research organizations, and pharmaceutical companies are contributing to propelling the market growth for whole genome sequencing.
Major vendors in the global whole genome sequencing market are Illumina, Inc., Thermo Fisher Scientific, Inc., Oxford Nanopore Technologies, Pacific Biosciences of California, Inc., BGI, QIAGEN, Agilent Technologies, ProPhase Labs, Inc. (Nebula Genomics), Psomagen, Azenta US, Inc. (GENEWIZ), and Others.
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting and Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Key Market Development
- In September 2024, MGI Tech Co., Ltd., a company committed to building core tools and technologies that drive innovation in life science, announced the global rights to commercialize and distribute the new sequencing products CycloneSEQ-WT02 and CycloneSEQ-WY01.
Market Segment
This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the whole genome sequencing market based on the below-mentioned segments:
Global Whole Genome Sequencing Market, By Product & Service
- Instruments
- Consumables
- Services
Global Whole Genome Sequencing Market, By Application
- Human Whole Genome Sequencing
- Plant Whole Genome Sequencing
- Animal Whole Genome Sequencing
- Microbial Whole Genome Sequencing
Global Whole Genome Sequencing Market, By End-use
- Academic & Research Institutes
- Hospitals & Clinics
- Pharmaceutical & Biotechnology Companies
- Others
Global Whole Genome Sequencing Market, By Regional Analysis
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of the Middle East & Africa
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?